Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 39, 2015 - Issue 4
232
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Heart Rate Variability for Early Detection of Iron Overload Cardiomyopathy in β-Thalassemia Patients

, , , , &
Pages 281-286 | Received 15 Apr 2014, Accepted 09 Nov 2014, Published online: 01 Jun 2015

References

  • Galanello R, Origa R. β-Thalassemia. Orphanet J Rare Dis. 2010;5:11. doi: 10.1186/1750-1172-5-11
  • Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004;89(10):1187–1193
  • Zurlo MG, De Stefano P, Borgna-Pignatti C, et al. Survival and causes of death in thalassaemia major. Lancet. 1989;2(8653):27–30
  • Ehlers KH, Giardina PJ, Lesser ML, et al. Prolonged survival in patients with β-thalassemia major treated with deferoxamine. J Pediatr. 1991;118(4 Pt 1):540–545
  • Tanner MA, Galanello R, Dessi C, et al. Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction. J Cardiovasc Magn Reson. 2008;10:12. doi: 10.1186/1532-429X-10–12
  • Ladis V, Chouliaras G, Berdousi H, et al. Longitudinal study of survival and causes of death in patients with thalassemia major in Greece. Ann N Y Acad Sci. 2005;1054:445–450
  • Olivieri NF, Nathan DG, MacMillan JH, et al. Survival in medically treated patients with homozygous β-thalassemia. N Engl J Med. 1994;331(9):574–578
  • Kolnagou A, Economides C, Eracleous E, Kontoghiorghes GJ. Low serum ferritin levels are misleading for detecting cardiac iron overload and increase the risk of cardiomyopathy in thalassemia patients. The importance of cardiac iron overload monitoring using magnetic resonance imaging T2 and T2*. Hemoglobin. 2006;30(2):219–227
  • Franzoni F, Galetta F, Di Muro C, et al. Heart rate variability and ventricular late potentials in β-thalassemia major. Haematologica. 2004;89(2):233–234
  • Rutjanaprom W, Kanlop N, Charoenkwan P, et al. Heart rate variability in β-thalassemia patients. Eur J Haematol. 2009;83(5):483–489
  • Kardelen F, Tezcan G, Akcurin G, et al. Heart rate variability in patients with thalassemia major. Pediatr Cardiol. 2008;29(5):935–939
  • Oztarhan K, Delibas Y, Salcioglu Z, et al. Assessment of cardiac parameters in evaluation of cardiac functions in patients with thalassemia major. Pediatr Hematol Oncol. 2012;29(3):220–234
  • Ma Q, Wang B, Fu G, et al. Heart rate variability in children with β-thalassemia major. Zhongguo Dang Dai Er Ke Za Zhi. 2011;13(8):654–656
  • Gurses D, Ulger Z, Levent E, et al. Time domain heart rate variability analysis in patients with thalassaemia major. Acta Cardiol. 2005;60(5):477–481
  • Koonrungsesomboon N, Chattipakorn SC, Fucharoen S, Chattipakorn N. Early detection of cardiac involvement in thalassemia: From bench to bedside perspective. World J Cardiol. 2013;5(8):270–279
  • Thephinlap C, Phisalaphong C, Lailerd N, et al. Reversal of cardiac iron loading and dysfunction in thalassemic mice by curcuminoids. Med Chem. 2011;7(1):62–69
  • Singh S, Hider RC, Porter JB. A direct method for quantification of non-transferrin-bound iron. Anal Biochem. 1990;186(2):320–323
  • Rajendra Acharya U, Paul Joseph K, Kannathal N, et al. Heart rate variability: A review. Med Biol Eng Comput. 2006;44(12):1031–1051
  • Kumfu S, Chattipakorn S, Chinda K, et al. T-type calcium channel blockade improves survival and cardiovascular function in thalassemic mice. Eur J Haematol. 2012;88(6):535–548
  • Romero Mestre JC, Hernández A, Agramonte O, Hernández P. Cardiovascular autonomic dysfunction in sickle cell anemia: A possible risk factor for sudden death? Clin Auton Res. 1997;7(3):121–125
  • Yokusoglu M, Nevruz O, Baysan O, et al. The altered autonomic nervous system activity in iron deficiency anemia. Tohoku J Exp Med. 2007;212(4):397–402
  • Sözen AB, Demirel S, Akkaya V, et al. Autonomic dysfunction in vitamin B12 deficiency: A heart rate variability study. J Auton Nerv Syst. 1998;71(1):25–27
  • Kirk P, Roughton M, Porter JB, et al. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation. 2009;120(20):1961–1968
  • Modell B, Khan M, Darlison M, et al. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2008;10:42. doi: 10.1186/1532–429X-10–42
  • Chouliaras G, Berdoukas V, Ladis V, et al. Impact of magnetic resonance imaging on cardiac mortality in thalassemia major. J Magn Reson Imaging. 2011;34(1):56–59

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.